Laobaixing Pharmacy (603883) - Total Liabilities

Latest as of September 2025: CN¥13.13 Billion CNY ≈ $1.92 Billion USD

Based on the latest financial reports, Laobaixing Pharmacy (603883) has total liabilities worth CN¥13.13 Billion CNY (≈ $1.92 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603883 cash generation efficiency to assess how effectively this company generates cash.

Laobaixing Pharmacy - Total Liabilities Trend (2011–2024)

This chart illustrates how Laobaixing Pharmacy's total liabilities have evolved over time, based on quarterly financial data. Check 603883 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Laobaixing Pharmacy Competitors by Total Liabilities

The table below lists competitors of Laobaixing Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
Voyager Technologies, Inc. NYSE:VOYG	USA	$109.31 Million
Vaisala Oyj A HE:VAIAS	Finland	€270.30 Million
Richelieu Hardware Ltd. TO:RCH	Canada	CA$479.24 Million
Five-Star Business Finance Limited NSE:FIVESTAR	India	Rs86.28 Billion
Shanxi Lanhua Sci-Tech Venture Co Ltd SHG:600123	China	CN¥21.48 Billion
Innovative Medical Management Co Ltd SHE:002173	China	CN¥388.70 Million
Hoist Finance AB ST:HOFI	Sweden	Skr53.03 Billion
Asian Star Anchor Chain Co Ltd Jiangsu SHG:601890	China	CN¥1.61 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Laobaixing Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Laobaixing Pharmacy market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.93	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.65	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Laobaixing Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Laobaixing Pharmacy (2011–2024)

The table below shows the annual total liabilities of Laobaixing Pharmacy from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥14.99 Billion ≈ $2.19 Billion	+7.51%
2023-12-31	CN¥13.94 Billion ≈ $2.04 Billion	-2.50%
2022-12-31	CN¥14.30 Billion ≈ $2.09 Billion	+17.41%
2021-12-31	CN¥12.18 Billion ≈ $1.78 Billion	+87.99%
2020-12-31	CN¥6.48 Billion ≈ $948.04 Million	+7.09%
2019-12-31	CN¥6.05 Billion ≈ $885.24 Million	+18.26%
2018-12-31	CN¥5.12 Billion ≈ $748.55 Million	+42.18%
2017-12-31	CN¥3.60 Billion ≈ $526.47 Million	+21.37%
2016-12-31	CN¥2.96 Billion ≈ $433.78 Million	+96.50%
2015-12-31	CN¥1.51 Billion ≈ $220.75 Million	+4.47%
2014-12-31	CN¥1.44 Billion ≈ $211.31 Million	+14.31%
2013-12-31	CN¥1.26 Billion ≈ $184.85 Million	+43.11%
2012-12-31	CN¥882.72 Million ≈ $129.17 Million	-3.30%
2011-12-31	CN¥912.83 Million ≈ $133.58 Million	--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers

Market Cap

$1.54 Billion

CN¥10.55 Billion CNY

Market Cap Rank

#7314 Global

#1746 in China

Share Price

CN¥13.90

Change (1 day)

-0.71%

52-Week Range

CN¥12.89 - CN¥22.52

All Time High

CN¥331.82